Sang-hun Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Author Correction: SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.
Journal: EMBO molecular medicine
Published: August 11, 2025
Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson's disease pathogenesis.
Journal: The Journal of clinical investigation
Published: April 28, 2025
Canonical cortico-hippocampal dynamics underlie memory of navigational episodes and its early decline in aging.
Journal: Imaging neuroscience (Cambridge, Mass.)
Published: January 30, 2025
Human Pluripotent Stem Cell-Based Therapies for Parkinson's Disease: Challenges and Potential Solutions.
Journal: Yonsei medical journal
Published: December 26, 2024
Attractor dynamics of working memory explain a concurrent evolution of stimulus-specific and decision-consistent biases in visual estimation.
Journal: Neuron
Published: November 13, 2024
Autophagy controls neuronal differentiation by regulating the WNT-DVL signaling pathway.
Journal: Autophagy
Published: October 10, 2024
JMJD3 deficiency disturbs dopamine biosynthesis in midbrain and aggravates chronic inflammatory pain.
Journal: Acta neuropathologica communications
Published: September 25, 2024
Preparation of human astrocytes with potent therapeutic functions from human pluripotent stem cells using ventral midbrain patterning.
Journal: Journal of advanced research
Published: November 17, 2023
Bounded contribution of human early visual cortex to the topographic anisotropy in spatial extent perception.
Journal: Communications biology
Published: July 25, 2023
Determination of optimal injection current pattern for multichannel transcranial electrical stimulation without individual MRI using multiple head models.
Journal: Computer methods and programs in biomedicine
Published: July 20, 2023
Correction: Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology.
Journal: Molecular psychiatry
Published: July 10, 2023
Last Updated: 09/26/2026